297 related articles for article (PubMed ID: 16369780)
1. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
Ziereisen F; Dan B; Azzi N; Ferster A; Damry N; Christophe C
Pediatr Radiol; 2006 Mar; 36(3):205-12. PubMed ID: 16369780
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate.
Asato R; Akiyama Y; Ito M; Kubota M; Okumura R; Miki Y; Konishi J; Mikawa H
Cancer; 1992 Oct; 70(7):1997-2004. PubMed ID: 1525778
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
4. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
5. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
6. A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.
Reddick WE; Glass JO; Helton KJ; Langston JW; Li CS; Pui CH
AJNR Am J Neuroradiol; 2005 Oct; 26(9):2371-7. PubMed ID: 16219848
[TBL] [Abstract][Full Text] [Related]
7. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
[TBL] [Abstract][Full Text] [Related]
8. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate.
Reddick WE; Glass JO; Helton KJ; Langston JW; Xiong X; Wu S; Pui CH
AJNR Am J Neuroradiol; 2005 May; 26(5):1263-9. PubMed ID: 15891195
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate.
Glass JO; Reddick WE; Li CS; Laningham FH; Helton KJ; Pui CH
Magn Reson Imaging; 2006 Jul; 24(6):785-91. PubMed ID: 16824973
[TBL] [Abstract][Full Text] [Related]
11. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J
Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947
[TBL] [Abstract][Full Text] [Related]
12. Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy.
Hamamoto K; Oriuchi N; Kanazawa T; Higuchi T; Endo K
Pediatr Neurol; 2009 Apr; 40(4):306-9. PubMed ID: 19302946
[TBL] [Abstract][Full Text] [Related]
13. Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.
Pande AR; Ando K; Ishikura R; Nagami Y; Ogawa M; Kamikonya N; Kaneda Y; Tanizawa T; Nakao N
Radiat Med; 2006 Aug; 24(7):515-9. PubMed ID: 17058146
[TBL] [Abstract][Full Text] [Related]
14. MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy.
Oka M; Terae S; Kobayashi R; Sawamura Y; Kudoh K; Tha KK; Yoshida M; Kaneda M; Suzuki Y; Miyasaka K
Neuroradiology; 2003 Jul; 45(7):493-7. PubMed ID: 12761601
[TBL] [Abstract][Full Text] [Related]
15. Quantitative MRI assessment of leukoencephalopathy.
Reddick WE; Glass JO; Langston JW; Helton KJ
Magn Reson Med; 2002 May; 47(5):912-20. PubMed ID: 11979570
[TBL] [Abstract][Full Text] [Related]
16. Pure methotrexate encephalopathy presenting with seizures: CT and MRI features.
Lövblad K; Kelkar P; Ozdoba C; Ramelli G; Remonda L; Schroth G
Pediatr Radiol; 1998 Feb; 28(2):86-91. PubMed ID: 9472050
[TBL] [Abstract][Full Text] [Related]
17. Subacute encephalopathy after combination chemotherapy including moderate-dose methotrexate in a patient with gastric cancer.
Genvresse I; Dietzmann A; Massenkeil G; Späth-Schwalbe E; Possinger K
Anticancer Drugs; 1999 Mar; 10(3):293-4. PubMed ID: 10327035
[TBL] [Abstract][Full Text] [Related]
18. Treatment-related disseminated necrotizing leukoencephalopathy with characteristic contrast enhancement of the white matter.
Laxmi SN; Takahashi S; Matsumoto K; Higano S; Kurihara N; Imaizumi M; Abe K; Itoyama Y; Sakamoto K
Radiat Med; 1996; 14(6):303-7. PubMed ID: 9132810
[TBL] [Abstract][Full Text] [Related]
19. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy.
Chu WC; Chik KW; Chan YL; Yeung DK; Roebuck DJ; Howard RG; Li CK; Metreweli C
Radiology; 2003 Dec; 229(3):659-69. PubMed ID: 14576448
[TBL] [Abstract][Full Text] [Related]
20. [Transient subacute encephalopathy induced by high-dose methotrexate treatment in children with acute lymphoblastic leukemia and malignant lymphoma].
Sasazaki Y; Asami K; Utsumi J
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1851-7. PubMed ID: 1519928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
